Keyword: Fabrazyme

News

Top-Selling Drugs for Ultra-Rare Diseases

03.01.2013 - Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...

News

Sanofi Says Gains Control Of Genzyme

04.04.2011 - French drugmaker Sanofi-Aventis completed its improved $20.1 billion offer for Genzyme allowing it to begin merging the U.S. biotech into its business and add rare diseases to its...

News

Sanofi CVRs Tied To Genzyme May Start Trading April 4

30.03.2011 - Certificates related to Sanofi-Aventis's $20.1 billion acquisition of U.S. biotech firm Genzyme could begin trading on Nasdaq as soon as April 4, depending on the outcome of its...

News

Genzyme Meets First Consent Decree Deadline

25.11.2010 - Genzyme Corp has met the first in a series of deadlines imposed by U.S. regulators for fixing problems at its Boston plant, a milestone that could bolster the biotech company's...